CN104257560A - Aloe facial cleanser and preparation method thereof - Google Patents
Aloe facial cleanser and preparation method thereof Download PDFInfo
- Publication number
- CN104257560A CN104257560A CN201410539505.5A CN201410539505A CN104257560A CN 104257560 A CN104257560 A CN 104257560A CN 201410539505 A CN201410539505 A CN 201410539505A CN 104257560 A CN104257560 A CN 104257560A
- Authority
- CN
- China
- Prior art keywords
- aloe
- acid
- parts
- salt
- puerarin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000011399 aloe vera Nutrition 0.000 title claims abstract description 55
- 241001116389 Aloe Species 0.000 title claims abstract description 47
- 230000001815 facial effect Effects 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims abstract description 29
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 claims abstract description 28
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims abstract description 28
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 claims abstract description 26
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 claims abstract description 26
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000012153 distilled water Substances 0.000 claims abstract description 6
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 28
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 27
- 229930195729 fatty acid Natural products 0.000 claims description 27
- 239000000194 fatty acid Substances 0.000 claims description 27
- 150000004665 fatty acids Chemical class 0.000 claims description 27
- 229940069521 aloe extract Drugs 0.000 claims description 21
- 239000011734 sodium Substances 0.000 claims description 18
- 229910052708 sodium Inorganic materials 0.000 claims description 18
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 17
- 239000003921 oil Substances 0.000 claims description 17
- 235000019198 oils Nutrition 0.000 claims description 17
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims description 16
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 15
- 235000013922 glutamic acid Nutrition 0.000 claims description 15
- 239000004220 glutamic acid Substances 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 14
- ZNLQDZISIWGUNG-UHFFFAOYSA-L [Na+].C(CCCCCCCCCCCCCCC)C1=C(C(=C(C=C1)S(=O)(=O)[O-])OC1=CC=CC=C1)S(=O)(=O)[O-].[Na+] Chemical compound [Na+].C(CCCCCCCCCCCCCCC)C1=C(C(=C(C=C1)S(=O)(=O)[O-])OC1=CC=CC=C1)S(=O)(=O)[O-].[Na+] ZNLQDZISIWGUNG-UHFFFAOYSA-L 0.000 claims description 14
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 claims description 14
- 235000019864 coconut oil Nutrition 0.000 claims description 14
- 239000003240 coconut oil Substances 0.000 claims description 14
- 235000012343 cottonseed oil Nutrition 0.000 claims description 14
- JMGZBMRVDHKMKB-UHFFFAOYSA-L disodium;2-sulfobutanedioate Chemical compound [Na+].[Na+].OS(=O)(=O)C(C([O-])=O)CC([O-])=O JMGZBMRVDHKMKB-UHFFFAOYSA-L 0.000 claims description 14
- 229960003720 enoxolone Drugs 0.000 claims description 14
- 125000005456 glyceride group Chemical group 0.000 claims description 14
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- HYCSHFLKPSMPGO-UHFFFAOYSA-N 3-hydroxypropyl dihydrogen phosphate Chemical compound OCCCOP(O)(O)=O HYCSHFLKPSMPGO-UHFFFAOYSA-N 0.000 claims description 12
- 229910019142 PO4 Inorganic materials 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 12
- 239000010452 phosphate Substances 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- 239000008107 starch Substances 0.000 claims description 12
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 10
- LISIOKIJVNSIGF-UHFFFAOYSA-N CCCN.CN(C)CC(O)=O Chemical compound CCCN.CN(C)CC(O)=O LISIOKIJVNSIGF-UHFFFAOYSA-N 0.000 claims description 10
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 239000002537 cosmetic Substances 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 206010040829 Skin discolouration Diseases 0.000 claims description 2
- 244000186892 Aloe vera Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 239000000284 extract Substances 0.000 abstract description 6
- 239000006260 foam Substances 0.000 abstract description 4
- 230000004224 protection Effects 0.000 abstract description 4
- 230000002087 whitening effect Effects 0.000 abstract description 3
- XEFZJVIUYRSRFX-UHFFFAOYSA-N 2-(3-hexadecylphenoxy)benzene-1,4-disulfonic acid Chemical compound CCCCCCCCCCCCCCCCC1=CC=CC(OC=2C(=CC=C(C=2)S(O)(=O)=O)S(O)(=O)=O)=C1 XEFZJVIUYRSRFX-UHFFFAOYSA-N 0.000 abstract description 2
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 24
- 239000000203 mixture Substances 0.000 description 15
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 14
- 229960002989 glutamic acid Drugs 0.000 description 14
- -1 hydroxyethyl diamine Chemical class 0.000 description 10
- 235000013336 milk Nutrition 0.000 description 10
- 239000008267 milk Substances 0.000 description 10
- 210000004080 milk Anatomy 0.000 description 10
- 244000144927 Aloe barbadensis Species 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 208000003351 Melanosis Diseases 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 5
- 230000002107 myocardial effect Effects 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 208000037259 Amyloid Plaque Diseases 0.000 description 3
- 206010008570 Chloasma Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 3
- 241000234280 Liliaceae Species 0.000 description 3
- 244000046146 Pueraria lobata Species 0.000 description 3
- 208000026137 Soft tissue injury Diseases 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229940120146 EDTMP Drugs 0.000 description 2
- 240000001972 Gardenia jasminoides Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 235000009392 Vitis Nutrition 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000015114 central nervous system disease Diseases 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229930182491 iridoid glucoside Natural products 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940046892 lead acetate Drugs 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 2
- 235000011285 magnesium acetate Nutrition 0.000 description 2
- 239000011654 magnesium acetate Substances 0.000 description 2
- 229940069446 magnesium acetate Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910000474 mercury oxide Inorganic materials 0.000 description 2
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- PUNXVEAWLAVABA-UHFFFAOYSA-N 1,2,3,4-tetrahydroanthracene;1,2,5,6-tetrahydroanthracene Chemical compound C1=CC=C2C=C(CCCC3)C3=CC2=C1.C1=CCCC2=C1C=C1CCC=CC1=C2 PUNXVEAWLAVABA-UHFFFAOYSA-N 0.000 description 1
- BPSYZMLXRKCSJY-UHFFFAOYSA-N 1,3,2-dioxaphosphepan-2-ium 2-oxide Chemical compound O=[P+]1OCCCCO1 BPSYZMLXRKCSJY-UHFFFAOYSA-N 0.000 description 1
- MUVQKFGNPGZBII-UHFFFAOYSA-N 1-anthrol Chemical compound C1=CC=C2C=C3C(O)=CC=CC3=CC2=C1 MUVQKFGNPGZBII-UHFFFAOYSA-N 0.000 description 1
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 244000242092 Aloe saponaria Species 0.000 description 1
- HKIKAXXIWJHWLY-ZIIYPAMZSA-N Aloesin Chemical compound C=12OC(CC(=O)C)=CC(=O)C2=C(C)C=C(O)C=1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HKIKAXXIWJHWLY-ZIIYPAMZSA-N 0.000 description 1
- HKIKAXXIWJHWLY-QEVGBQTESA-N Aloesin Natural products O=C(CC=1Oc2c([C@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)c(O)cc(C)c2C(=O)C=1)C HKIKAXXIWJHWLY-QEVGBQTESA-N 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- KNLHGXVYZRQSJZ-UHFFFAOYSA-N Eleutherol Natural products OC1=C2C(OC)=CC=CC2=CC2=C1C(C)OC2=O KNLHGXVYZRQSJZ-UHFFFAOYSA-N 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- DCTLJGWMHPGCOS-UHFFFAOYSA-N Osajin Chemical compound C1=2C=CC(C)(C)OC=2C(CC=C(C)C)=C(O)C(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DCTLJGWMHPGCOS-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 208000014139 Retinal vascular disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- OUZCFMSJGDEXRT-UHFFFAOYSA-N Scandinone Natural products O=C1C=2C(OC)=C(CC=C(C)C)C=3OC(C)(C)C=CC=3C=2OC=C1C1=CC=C(O)C=C1 OUZCFMSJGDEXRT-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XBDYBAVJXHJMNQ-UHFFFAOYSA-N Tetrahydroanthracene Natural products C1=CC=C2C=C(CCCC3)C3=CC2=C1 XBDYBAVJXHJMNQ-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- QILXPCHTWXAUHE-UHFFFAOYSA-N [Na].NCCN Chemical compound [Na].NCCN QILXPCHTWXAUHE-UHFFFAOYSA-N 0.000 description 1
- OQRDSLOUOFIGSC-UHFFFAOYSA-N [Na].[Na].[Na].[Na].[Na].NCCNCCN Chemical compound [Na].[Na].[Na].[Na].[Na].NCCNCCN OQRDSLOUOFIGSC-UHFFFAOYSA-N 0.000 description 1
- PDIZYYQQWUOPPK-UHFFFAOYSA-N acetic acid;2-(methylamino)acetic acid Chemical compound CC(O)=O.CC(O)=O.CNCC(O)=O PDIZYYQQWUOPPK-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- KFJNVVJUICKJEQ-LQDZTQBFSA-N aloenin Chemical compound O1C(=O)C=C(OC)C=C1C1=C(C)C=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 KFJNVVJUICKJEQ-LQDZTQBFSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 239000007957 coemulsifier Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- RWIGWWBLTJLKMK-UHFFFAOYSA-N diethoxyphosphorylmethanol Chemical compound CCOP(=O)(CO)OCC RWIGWWBLTJLKMK-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- KKGXXVNMUUFEDZ-UHFFFAOYSA-L disodium;2-sulfonatododecanoate Chemical compound [Na+].[Na+].CCCCCCCCCCC(C([O-])=O)S([O-])(=O)=O KKGXXVNMUUFEDZ-UHFFFAOYSA-L 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 210000004024 hepatic stellate cell Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- OOJZCXFXPZGUBJ-RITPCOANSA-N hypoglycin Chemical compound OC(=O)[C@@H](N)C[C@H]1CC1=C OOJZCXFXPZGUBJ-RITPCOANSA-N 0.000 description 1
- OOJZCXFXPZGUBJ-UHFFFAOYSA-N hypoglycin A Natural products OC(=O)C(N)CC1CC1=C OOJZCXFXPZGUBJ-UHFFFAOYSA-N 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 description 1
- 239000000626 magnesium lactate Substances 0.000 description 1
- 229960004658 magnesium lactate Drugs 0.000 description 1
- 235000015229 magnesium lactate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- YIXPUAYMZURQJH-UHFFFAOYSA-N non-2-enedioic acid Chemical compound OC(=O)CCCCCC=CC(O)=O YIXPUAYMZURQJH-UHFFFAOYSA-N 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- QWIDXEUVWSDDQX-SVMKZPJVSA-N octadecanoic acid;(z)-octadec-9-enoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O QWIDXEUVWSDDQX-SVMKZPJVSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 208000023088 sudden sensorineural hearing loss Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides aloe facial cleanser which is prepared by raw materials in parts by weight as follows: 2-4 parts of aloe extracts, 4-6 parts of geniposide, 3-5 parts of puerarin, 5-7 parts of acetyltalatisamine achyranthan, 20-30 parts of hexadecyl(sulfophenoxy) benzenesulfonic acid, disodium salt, 10-15 parts of coconut monoethanol amide, 5-7 parts of caprylic capric triglyceride and 150-180 parts of distilled water. The aloe facial cleanser has fine and stable foam, is mild in property, stable in viscosity and convenient to use, has low stimulation on skin, good environmental protection property and good use effect, and the aloe facial cleanser can have a better skin whitening effect after other extracts are added particularly.
Description
Technical field
The present invention relates to a kind of aloe facial cleaner and preparation method thereof, belong to daily-use chemical industry technical field.
Background technology
Along with the raising of people's living standard; demand for cosmetics is also more and more higher, the cleansing milk extensively sold in the market, and major part utilizes chemicals to make; easily cause skin allergy; also have other some side effect, and in price costly, be not suitable for a large amount of use; to skin, there is the less of protective effect; the fat protection composition even skin can secreted washes, thus makes skin very dry, serious meeting injury skin.Aloe facial cleaner also has a lot of report.As CN102772322 A discloses a kind of betaplex gentle cleansing milk, it comprises following component: amino acid/11 0-16 part, transparent fat acid 2-6 part, cleansing 1-5 part of alkalescence, Aloe gel 2-4 part, Mentholum 1-3 part, antiseptic 0.1-0.5 part, Flos Osmanthi Fragrantis extract 0.1-1 part, natural marine polysaccharide 2-8 part, wetting agent 5-7 part, Semen Vitis viniferae extract 0.5-2 part, all the other are deionized water.CN102860952 A discloses a kind of absolute oil cleansing milk, it is formulated by amine-oxides, sorbitol, Aloe gel, cocos nucifera oil diglycollic amide, triethanolamine, hydrolytic collagen and deionized water, and the weight portion of described each component is: amine-oxides: 30-40 part; Sorbitol: 8-10 part; Aloe gel: 4-5 part; Cocos nucifera oil diglycollic amide: 15-25 part; Triethanolamine: 10-12 part CN 103006507 A discloses a kind of aloe facial cleaner; comprise the raw material of following mass fraction: Aloe extraction solution 12-14 part; potassium palmitate 2-4 part; triethanolamine 1-3 part, sodium N-lauroyl sarcosinate 1-3 part, glycerol 3-5 part; lanoline 2-4 part; emulsifying agent 1-3 part, antiseptic 3-5 part, distilled water 50-60 part.Aloe facial cleaner of the present invention adopts aloe composition, has no side effect, and can also retain skin moisture while effectively clean dirt, existing clean effect preferably has again skin protection moisture-keeping functions.CN103356437 A discloses a kind of aloe facial cleaner, is made up of the raw material of following component: Aloe 4-7 part, red wine 2-3 part, salt 2-3 part, vinegar 2-3 part, water 40-60 part.What adopt in many aloe facial cleaner is single Aloe effective ingredient, and from skin comfort degree, moist degree aspect effect is bad.
Summary of the invention
Goal of the invention: the object of this invention is to provide a kind of aloe facial cleaner and preparation method thereof.
Technical scheme: the object of the invention is by following scheme realize:
A kind of aloe facial cleaner, be made up of the raw material of following weight portion: Aloe extract 2-4 part, geniposide 4-6 part, puerarin 3-5 part, Inokopolyose 5-7 part, cetyl sulfophenoxy benzenesulfonic acid disodium salt 20-30 part, coconut oil fatty acid monoethanolamide 10-15 part, N-cocamidopropyl propyl amide-DMG inner salt 30-36 part, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt 15-20 part, decanoyl/octanoyl glycerides 5-7 part, distilled water 150-180 part.
Described aloe facial cleaner, be made up of the raw material of following weight portion: Aloe extract 2-4 part, geniposide 4-6 part, puerarin 3-5 part, Inokopolyose 5-7 part, cetyl sulfophenoxy benzenesulfonic acid disodium salt 20-30 part, coconut oil fatty acid monoethanolamide 10-15 part, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt 30-36 part, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt 15-20 part, decanoyl/octanoyl glycerides 5-7 part, glutamic acid diacetic acid four sodium 2-4 part, succinyl glycyrrhetinic acid disodium 3-5 part, glucose fatty acid phosphate 2-4 part, hydroxypropyl phosphorate starch 1-3 part, distilled water 150-180 part.
The present invention can add chelating agen, described chelating agen is disodium EDTA, tetrasodium salt of EDTA, ethylenediamine tetramethylene phosphonic acid, hydroxymethyl phosphonic acid diethylester, diethylenetriamine penta sodium, hexapotassium, two hexene triamine five methylenephosphonic acids, diethylenetriamine pentamethylenophosphonic acid seven sodium salt, EDTMP six sodium salt, sodium ethylenediamine tetramethylenephosphonate, glutamic acid diacetic acid four sodium, succinyl glycyrrhetinic acid disodium, one in methyl-glycine diacetate tri-sodium and hydroxyethyl diamine tetraacethyl trisodium salt or its mixture.
The preparation method of described aloe facial cleaner, the preparation method of Aloe extract comprises the following steps: get fresh Aloe vera L.var. chinensis(Haw.)Berg. kind, peeling, by Aloe mesophyll homogenate, centrifugal, obtain Aloe juice, hydro-oxidation sodium adjust ph is 7.0-7.4, and spraying dry obtains Aloe extract.
Described aloe facial cleaner is preparing the application in skin-lightening cosmetic.
Aloe facial cleaner preparation method, containing following steps:
A) get Aloe extract, geniposide, puerarin, Inokopolyose respectively, cross 100 mesh sieves, mix homogeneously, adding distil water, stir 1-10min;
B) cetyl sulfophenoxy benzenesulfonic acid disodium salt, coconut oil fatty acid monoethanolamide, N-cocamidopropyl propyl amide-N is added, N-dimethylglycine inner salt, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, decanoyl/octanoyl glycerides, glutamic acid diacetic acid four sodium, succinyl glycyrrhetinic acid disodium, glucose fatty acid phosphate, hydroxypropyl phosphorate starch, be uniformly mixed.
Beneficial effect:
Aloe is commonly referred to as Aloe, originates in Mediterranean, Africa, is Liliaceae herbaceos perennial, and according to wild aloe kind kind more than 300 of textual criticism, be mainly distributed in the ground such as Africa, be a kind of Liliaceae herbaceous plant, it is perennial Liliaceae meat herbaceous plant.Containing abundant polysaccharide, protein, aminoacid, vitamin, organized enzyme and the trace element very useful to human body.Its characteristic component is Aloe anthraquinones etc., Aloe due to containing various bioactivators, at folks of china just by the natural drug as beauty treatment, hair care and treatment dermatosis, Folium Aloe clusters, in seat shape or be born in stem top, the normal lanceolar of leaf or leaf short wide, edge has sharp tooth to sting.Inflorescence is umbrella shape, total shape, spike, taper shape etc., and color is red, yellow or tool redness of the skin or complexion speckle, six, petal, gynoecium six pieces.The many Colaesces of perianth base portion become tubular.
The Aloe vera L.var. chinensis(Haw.)Berg. that the present invention uses is the mutation of Aloe vulgaris, has another name called the Chinese aloe aloe.Aloe vera L.var. chinensis(Haw.)Berg. stem is short, and leaf closely clusters, and seedling leaf becomes two row, and blade face blade back is adularescent speckle all.After leaf grows up to, white macula does not take off.Leaf is about 35 centimetres, wide 5-6 centimetre, plant likeness in form Aloe Barbadensis Miller.The Aloe vera L.var. chinensis(Haw.)Berg. individual plants in the south of Fujian Province is obviously little than Aloe Barbadensis Miller.The place of production: the provinces such as Fujian, Guangdong, Guangxi, Yunnan, Sichuan, Taiwan.Also have in In Yuanjiang Area, Yunnan Province, Hainan and island, Leizhou.There is certain medical value.The raw material that tender leaf can do Aloe salad eats.
Aloe main component: anthraquinone analog compound: aloin, aloe-emodin, different aloin, B aloin, produce the two glycoside of luxuriant growth emodin, aloe-emodin-8-glycoside, Aloearbonaside, Aloe resin B, alomycin, alochrysine, aloietic acid, aloaresic acid, aloresinotannol, aloxanthine, chrysophanol, chrysophanol monoglucoside, rear Mo Nate aloin, anthrol, different eleutherol glycoside, aloe saponaria glycoside I, II, helminthosporin, 7-hydroxyl aloin, tetrahydro anthracene Fructus Vitis viniferae glycoside.Carbohydrate: arabinose, galactose, glucose, mannose, rhamnose, xylose, alduronic acid, galacturonic acid, glucuronic acid, mannuronic acid, arabinose, cellulose, lignin.Aminoacid: galactosamine, glucamine amino acid alanine, lysine, proline, hydroxyproline, cystine, arginine, aspartic acid, glycine, glutamic acid, threonine, agedoite, histidine, tyrosine, tryptophan, valine, leucine, serine, isoleucine, phenylalanine, c-alanine, methionine, hypoglycin A.The compound of vitamin: VA, VB1, VB2, VB6, VC, VE, VH, nicotinic acid, folic acid, carotene, metal ion and vitamin.Organic acid: malic acid, citric acid, tartaric acid, succinic acid, cinnamic acid, fatty acid, succinic acid, lactic acid, P-coumaric acid, acetic acid, sad, the acid of capric acid, lauric acid, nonendioic acid, dodecylic acid, nutmeg pentadecanoic acid, Palmic acid, tridecanoic acid, stearic acid oleic acid, linoleic acid, arachidonic acid, magnesium lactate, calcium oxalate, 1-Hydroxy-1,2,3-propanetricarboxylic acid..Enzyme (peptide): amylase, cellulase, catalase, oxidase, lactic acid dehydrogenase, alkaline phosphatase, acid p'tase, glutamate pyruvate transaminase, glutamic oxaloacetic transaminase, GOT, Kallidin I enzyme allinase, angiotensin, lectins.
Geniposide is a kind of iridoid glucoside, soluble in water, is the main pharmacodynamics composition of Fructus Gardeniae.Geniposide all has significant curative effect to digestive system, cardiovascular system central nervous system disease of unifying, and in addition, geniposide also has the effect of certain antiinflammatory and treatment soft tissue injury.No. CAS: 24512-63-8, molecular weight: 388.37, density: 1.49g/cm3, boiling point: 622.2 DEG C, flash-point: 224 DEG C, Fructus Gardeniae derives from the dry mature fruit of Maguireothamnus speciosus Fructus Gardeniae Gardenia jasminoides Ellis.There is cathartic, analgesia, function of gallbladder promoting, antiinflammatory, treatment soft tissue injury and suppress gastric secretion and reduce the effects such as pancreatic amylase.Jasminoidin has multiple use, the fermentation of different condition, can make natural edible coloring agent gardenia blue and gardenia red, is also the material medicine being used for the treatment of the disease such as cardiovascular and cerebrovascular vessel, liver and gall and diabetes.Be a kind of iridoid glucoside, soluble in water, be the main pharmacodynamics composition of Fructus Gardeniae, content is with about the 3%-8% that do not coexist in the place of production.Geniposide can be hydrolyzed to genipin by beta-glucosidase.Modern study shows, geniposide all has significant curative effect to digestive system, cardiovascular system central nervous system disease of unifying, and in addition, geniposide also has the effect of certain antiinflammatory and treatment soft tissue injury.Geniposide, except medicinal, is also widely used in other field, as can be used as plant promoter, biological detection agent etc.
At present, the extracting method of geniposide generally adopts the organic solvent such as chloroform, dehydrated alcohol to extract in surname extraction bottle, obtain active component Fructus Gardeniae total glycosides total in Fructus Gardeniae, and then upper silicagel column is separated, with a certain proportion of methanol, chloroform mixed liquor eluting, eluent carries out recrystallization in acetone and obtains geniposide crystal, separablely in general 100g fruit of Fructus Gardeniae obtains about 4.0g geniposide.
Puerarin is yellow crystal, and water-soluble, methanol, ethanol, pyridine, be soluble in hot water, is insoluble in benzene, chloroform, ether etc., reacts displaing yellow with magnesium acetate, reacts in yellow mercury oxide with lead acetate.High-load is white, needle-shaped crystals powder, belongs to osajin.Have and improve immunity, strengthen myocardial contraction, protecting myocardial cell, reduces blood pressure, and has the effects such as antiplatelet aggregation.No. CAS: 3681-99-0, molecular formula: C21H20O9, molecular weight: 416.38, physicochemical property: yellow crystal, water-soluble, methanol, ethanol, pyridine, be soluble in hot water, be insoluble in benzene, chloroform, ether etc., react displaing yellow with magnesium acetate, react in yellow mercury oxide with lead acetate.Radix Puerariae derives from leguminous plant Pueraria lobota Pueraria lobata (Willd.) Ohwi root, Herba Gelsemii Elegantis P.thunbergiana Benth. root.Fusing point 187-189 DEG C.Low content be brown ceramic powder, high-load is white, needle-shaped crystals powder, have improve immunity, strengthen myocardial contraction, protecting myocardial cell, reduces blood pressure, and has the effects such as antiplatelet aggregation.Puerarin is on the impact of liver system: puerarin contains saponins compound, has protective effect to hepatic tissue immune impairment, C-29 position hydroxyl and C-5 " oxy radical can strengthen liver-protecting activity.Puerarin is absorbed by stomach can protect hepatic injury, induced activation apoptosis on hepatic stellate cells, effectively reverses the hepatic fibrosis of chemical induction, also has protective effect, have many-sided physiologically active simultaneously to the acute liver damage of tetrachloro-methane induction.Puerarin is on the impact of cardiovascular system: the total flavones in Radix Puerariae can increase brain and blood flow coronarius.Puerarin has obvious facilitation to the cerebral circulation of animal and human's body and peripheral circulation.Radix Puerariae total flavones improve the cerebrovascular tension force of hypertension and patients with coronary heart disease, elasticity and Pulsating quality confession because of etc. in all have gentle facilitation.Puerarin not only improves the normal brain activity microcirculation of human body, and also improves significantly to microcirculation disturbance, and main manifestations is that the amplitude of local microvascular blood flow and motion increases.The Microcirculation of Nailfold of puerarin to patients with sudden sensorineural hearing loss is also improved effect, can accelerate microvascular blood flow velocity, removes blood vessel loop congestion, improves the audition of patient.Puerarin has protective effect to hypoxic cardiac muscle, and puerarin obviously can reduce the oxygen consumption of ischemic myocardium, and cardioprotection is from the ultrastructure damage of ischemia again caused by the perfusion of port.Puerarin is the single composition flavonoid glycoside of one extracted from legume pueraria lobata root, there is blood circulation promoting and blood stasis dispelling, improve microcirculation, coronary artery dilator and the effect such as cerebrovascular, reduction myocardial oxygen consumption, its preparation puerarin injection is clinical is used for the treatment of cardiovascular and cerebrovascular disease and retinal vascular disease, retinopathy and sudden deafness etc.c
Inokopolyose is separation from Radix Achyranthis Bidentatae, extracts a kind of micromolecular polysaccharide compound obtained, and pharmacological testing shows that it has and improves body's immunity, leukocyte increasing, Tumor suppression transfer and the liver protecting function, and long-term taking is without any side effects.Inokopolyose be China's reported first there is immunocompetent micromolecular polysaccharide, compared with some known polysaccharide, it is little that Inokopolyose has molecular weight, no antigen, good water solubility, human body easily absorbs, chemical extraction steady quality, not only can be used as a kind of disease of Drug therapy immunologic hypofunction, as tumor, hepatitis etc., and can be used as a kind of immunostimulant and be developed to health product.Clinical preliminary test shows effectively to promote leukocyte, and the symptom such as simultaneously to receive to the stomach of patient, weak has clear improvement.
Above-mentioned Aloe is Aloe vera L.var. chinensis(Haw.)Berg., Classification system Aloe chinensis Berger, and geniposide, puerarin, Inokopolyose are all purchased from Xi'an and continuous heavy rain biological engineering company limited, and content is more than 98%.
Cetyl sulfophenoxy benzenesulfonic acid disodium salt, CA registration number: 65143-89-7, molecular formula is C28H42O7S2.2Na, English name: 51842 Hexadecyl (sulfophenoxy) benzenesulfonic acid, disodium salt.
Coconut oil fatty acid monoethanolamide CA registration number: 68140-00-1.
N-cocamidopropyl propyl amide-DMG inner salt, CA registration number: 86438-79-1, molecular formula is C19H38N2O3.
Hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, trade name: Emcol 4072 Coemulsifier, witco company of the U.S. produces.
Succinyl glycyrrhetinic acid disodium, cas number: 38841-48-4
Glutamic acid diacetic acid four sodium, cas number: 51981-21-6, molecular formula is C9H9NNa4O8, English name: 16896 L-Glutamic acid, N, N-bis (carboxymethyl)-, sodium salt (1:4).
Decanoyl/octanoyl glycerides, cas number: 65381-09-1, English name: 45755 Decanoyl/octanoyl-glycerides.
Glucose fatty acid phosphate, cas number: 1739-84-0.
Hydroxypropyl phosphorate starch, cas number: 53124-00-8.
Above-mentioned surfactant, antioxidant, chelating agen raw material are all purchased from Shanghai Fei Ge Chemical Co., Ltd..
Aloe facial cleaner of the present invention, foam exquisiteness is stable, and performance is gentle, and viscosity stablization is low to the zest of skin, and after special other extracts of interpolation, more can play whitening function, the feature of environmental protection is good, and result of use is good and convenient.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1, in conjunction with detailed description of the invention, the present invention is further described as follows:
Needed raw material weight proportion (unit: g) in table 1 various embodiments of the present invention
2, embodiment is prepared
The preparation of Aloe extract: get fresh Aloe vera L.var. chinensis(Haw.)Berg. kind 1000g, peeling, by Aloe mesophyll homogenate, centrifugal, obtain Aloe juice, hydro-oxidation sodium adjust ph is 7.2, and spraying dry obtains Aloe extract, and spray drying condition is inlet temperature is 100 DEG C, leaving air temp is 80 DEG C, temperature of charge is 80 DEG C, and atomizing pressure is 0.2 MPa, and spray velocity is 5ml/s.
Embodiment 1: by upper table 1, gets Aloe extract, geniposide, puerarin, Inokopolyose respectively, crosses 100 mesh sieves, mix homogeneously, adding distil water, stirs 10min; Add cetyl sulfophenoxy benzenesulfonic acid disodium salt, coconut oil fatty acid monoethanolamide, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, decanoyl/octanoyl glycerides, glutamic acid diacetic acid four sodium, succinyl glycyrrhetinic acid disodium, glucose fatty acid phosphate, hydroxypropyl phosphorate starch, be uniformly mixed.
Embodiment 2: by upper table 1, gets Aloe extract, puerarin, Inokopolyose respectively, crosses 100 mesh sieves, mix homogeneously, adding distil water, stirs 10min; Add cetyl sulfophenoxy benzenesulfonic acid disodium salt, coconut oil fatty acid monoethanolamide, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, decanoyl/octanoyl glycerides, glutamic acid diacetic acid four sodium, succinyl glycyrrhetinic acid disodium, glucose fatty acid phosphate, hydroxypropyl phosphorate starch, be uniformly mixed.
Embodiment 3: by upper table 1, gets Aloe extract, geniposide, Inokopolyose respectively, crosses 100 mesh sieves, mix homogeneously, adding distil water, stirs 10min; Add cetyl sulfophenoxy benzenesulfonic acid disodium salt, coconut oil fatty acid monoethanolamide, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, decanoyl/octanoyl glycerides, glutamic acid diacetic acid four sodium, succinyl glycyrrhetinic acid disodium, glucose fatty acid phosphate, hydroxypropyl phosphorate starch, be uniformly mixed.
Embodiment 4: by upper table 1, gets Aloe extract, geniposide, puerarin respectively, crosses 100 mesh sieves, mix homogeneously, adding distil water, stirs 10min; Add cetyl sulfophenoxy benzenesulfonic acid disodium salt, coconut oil fatty acid monoethanolamide, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, decanoyl/octanoyl glycerides, glutamic acid diacetic acid four sodium, succinyl glycyrrhetinic acid disodium, glucose fatty acid phosphate, hydroxypropyl phosphorate starch, be uniformly mixed.
Embodiment 5: by upper table 1, gets Aloe extract, geniposide, puerarin, Inokopolyose respectively, crosses 100 mesh sieves, mix homogeneously, adding distil water, stirs 10min; Add cetyl sulfophenoxy benzenesulfonic acid disodium salt, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt, decanoyl/octanoyl glycerides, glutamic acid diacetic acid four sodium, succinyl glycyrrhetinic acid disodium, glucose fatty acid phosphate, hydroxypropyl phosphorate starch, be uniformly mixed.
Embodiment 6: by upper table 1, gets Aloe extract, geniposide, puerarin, Inokopolyose respectively, crosses 100 mesh sieves, mix homogeneously, adding distil water, stirs 10min; Add coconut oil fatty acid monoethanolamide, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, decanoyl/octanoyl glycerides, glutamic acid diacetic acid four sodium, succinyl glycyrrhetinic acid disodium, glucose fatty acid phosphate, hydroxypropyl phosphorate starch, be uniformly mixed.
Embodiment 7: by upper table 1, gets Aloe extract, geniposide, puerarin, Inokopolyose respectively, crosses 100 mesh sieves, mix homogeneously, adding distil water, stirs 10min; Add cetyl sulfophenoxy benzenesulfonic acid disodium salt, coconut oil fatty acid monoethanolamide, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, decanoyl/octanoyl glycerides, glutamic acid diacetic acid four sodium, glucose fatty acid phosphate, be uniformly mixed.
Embodiment 8: by upper table 1, gets Aloe extract, geniposide, puerarin, Inokopolyose respectively, crosses 100 mesh sieves, mix homogeneously, adding distil water, stirs 10min; Add cetyl sulfophenoxy benzenesulfonic acid disodium salt, coconut oil fatty acid monoethanolamide, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, decanoyl/octanoyl glycerides, succinyl glycyrrhetinic acid disodium, hydroxypropyl phosphorate starch, be uniformly mixed.
3, effect example
Test one: to the clinical research of face's chloasma, freckle, senile plaque, butterfly spot
Test method: respectively select face have chloasma, freckle, senile plaque, butterfly spot volunteer 30 example test, respectively with cleansing milk one bottle of about 150g that embodiment 1-8 is obtained, wash one's face once with the warm water of 25-45 DEG C after getting up early morning every day and before sleeping, wash one's face at every turn and fully massage face, make cleansing milk stop about 1 minute in face, repeat above operation at every turn.Its effective percentage (%) is added up after test carries out 40 days.Criterion of therapeutical effect: 1. effective: subjective symptoms has and alleviates significantly or disappear.2. effective: subjective symptoms have to a certain degree alleviate but not too obvious.3.: invalid: face's speckle still obviously or do not alleviate.Result of the test sees the following form 2:
Table 2 embodiment 1-8 is to face's speckle dispelling result of the test
| Sample source | Volunteer (example) | Effective | Effectively | Invalid | Total effective rate (%) |
| Embodiment 1 | 30 | 15 | 12 | 3 | 90 |
| Embodiment 2 | 30 | 11 | 13 | 6 | 80 |
| Embodiment 3 | 30 | 10 | 16 | 4 | 86.7 |
| Embodiment 4 | 30 | 12 | 13 | 5 | 83.3 |
| Embodiment 5 | 30 | 14 | 14 | 2 | 93.3 |
| Embodiment 6 | 30 | 12 | 15 | 3 | 90 |
| Embodiment 7 | 30 | 10 | 18 | 2 | 93.3 |
| Embodiment 8 | 30 | 10 | 17 | 3 | 90 |
Table 2 shows: embodiment 1-8 all has good effect to face's chloasma, freckle, senile plaque, butterfly spot; Wherein embodiment 1,5-8 is better than embodiment 2-4, illustrates that Aloe extract, geniposide, puerarin, Inokopolyose compatibility result of use are better.
Test two: to the clinical research of face's whitening
Test method: select face respectively, volunteer 50 example that the wing of nose has obvious blackhead tests, respectively with cleansing milk one bottle of about 150g that embodiment 1-8 is obtained, wash one's face once with the warm water of 25-45 DEG C after getting up early morning every day and before sleeping, wash one's face at every turn and fully massage face, make cleansing milk stop about 1 minute in face, repeat above operation at every turn.Its effective percentage (%) is added up after test carries out 30 days.Criterion of therapeutical effect: 1. effective: blackhead thoroughly disappears.2. effective: blackhead has desalination to a certain degree.3.: invalid: blackhead still obviously or do not alleviate.Result of the test sees the following form 3:
Table 3 embodiment 1-8 is to the result of the test of blackhead
| Sample source | Volunteer (example) | Effective | Effectively | Invalid | Total effective rate (%) |
| Embodiment 1 | 30 | 12 | 18 | 0 | 100 |
| Embodiment 2 | 30 | 12 | 15 | 3 | 90 |
| Embodiment 3 | 30 | 14 | 13 | 3 | 90 |
| Embodiment 4 | 30 | 14 | 12 | 4 | 86.7 |
| Embodiment 5 | 30 | 16 | 14 | 0 | 100 |
| Embodiment 6 | 30 | 18 | 10 | 2 | 93.3 |
| Embodiment 7 | 30 | 10 | 19 | 1 | 96.7 |
| Embodiment 8 | 30 | 14 | 16 | 0 | 100 |
Table 3 shows, and: embodiment 1-8 all has blackhead and good cleanly dispels effect; Wherein embodiment 1,5-8 is better than embodiment 2-4, illustrates that Aloe extract, geniposide, puerarin, Inokopolyose compatibility result of use are better.
Test three: on the impact of clean test, the test of gentle zest, stability test
Test method: described clean test is: will prepare embodiment 1-8, issues 50 testers respectively and uses.Tester uses during sample and cleans according to identical method, and often kind of a sample uses 2 weeks.Tester according to oneself feel mark.Standards of grading take ten point system, and 1 point the poorest, and 10 points best.
The concrete clean method of tester is: after first using clear water to drench skin, use product of the present invention in right amount in the palm of the hand, after rubbing out foam gently, is coated with and face, and gently rubs face skin one minute; Then rinse well with clear water, repeat above-mentioned steps, each sample determination 6 times, the results are shown in Table 3.
Described gentle zest test is: will prepare case study on implementation 1-8, and issue 50 testers respectively and contrast use.Often kind of a sample uses 2 weeks, tester according to oneself feel appraise through comparison.Content on probation comprises: with or without excitement, with or without pruritus, facial skin with or without general red, contact around eyes with or without general red.Evaluation criterion has been taked, slightly, nothing, test result is shown in 4.
The concrete method of testing of tester is: after first using clear water to drench skin, use product of the present invention in right amount in the palm of the hand, after rubbing out foam gently, be coated with and face and circumference of eyes, and gently rub face skin one minute, then rinse well with clear water, circumference of eyes is also skin one minute around massaging eyes gently, then rinse well with clear water, repeat above-mentioned steps, each sample test six times.(remarks: above Ocular irritation test is because of with in clear water flushing process, does not avoid eyes, the general red phenomenon of generation)
Table 4 cleansing milk result of use of the present invention evaluation table
| Sample source | Skin comfort degree | Bath skinfeel | Clean up sense | Moisturizing effect after dry | Foaming abundancy sense |
| Embodiment 1 | 9 | 9.2 | 9.5 | 9.2 | 9 |
| Embodiment 2 | 9.2 | 9.3 | 9 | 9.1 | 9.2 |
| Embodiment 3 | 9.7 | 9.5 | 9.1 | 8.5 | 8.9 |
| Embodiment 4 | 9.1 | 9.1 | 9.4 | 9.3 | 9.1 |
| Embodiment 5 | 7.5 | 7.8 | 8.6 | 8.8 | 7.4 |
| Embodiment 6 | 8.1 | 7.6 | 7.9 | 7.3 | 8.2 |
| Embodiment 7 | 7.9 | 7.8 | 8.3 | 7.8 | 8.4 |
| Embodiment 8 | 7.4 | 8.2 | 8.0 | 7.8 | 7.6 |
Table 4 shows: embodiment 1-4 skin comfort degree, bath skinfeel, clean up sense, moisturizing effect after dry, foaming abundancy sense is significantly better than embodiment 5-8, cetyl sulfophenoxy benzenesulfonic acid disodium salt is described, coconut oil fatty acid monoethanolamide, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt, after the surfactant compounds such as decanoyl/octanoyl glycerides, chelating agen glutamic acid diacetic acid four sodium and succinyl glycyrrhetinic acid disodium composite, there is gentle non-stimulated effect, than being used alone wherein one or more surfactants or chelating agen better effects if.
Test four: on the impact of cleansing milk viscosity
Test method: viscosity measurement of the present invention uses rotor-type Rotary Viscosimeter (the NDJ-8S rotational viscometer that Shanghai Ping Xuan scientific instrument company limited produces) to measure, and select No. 4 rotors, rotating speed is 3rpm, and measuring temperature is 25 DEG C.Test sample 10ml is drawn with 10ml disposable syringe, syringe needle one end seals, vertically be fixed in the environment of 25 DEG C, supporting for NDJ-8S rotational viscometer No. 4 rotors are installed on rotational viscometer, regulate rotational viscometer in level, be dipped vertically into and fill in the 10ml syringe of test sample, the graduation mark of rotor and the liquid level of test sample maintain an equal level, and leave standstill after 10 minutes, open rotor, adjusting rotary speed is 3rpm, starts to measure.Measure the k value of 0h, 24h, 48h, 72h respectively.The results are shown in Table 5.
Effect appraise table (3 revs/min) unit: the Pa.s of table 5 cleansing milk viscosity of the present invention
| Sample source | 0h | 24h | 48h | 72h |
| Embodiment 1 | 14 | 13 | 15 | 14 |
| Embodiment 2 | 15 | 16 | 15 | 14 |
| Embodiment 3 | 14 | 13 | 16 | 13 |
| Embodiment 4 | 14 | 16 | 14 | 14 |
| Embodiment 5 | 13 | 15 | 15 | 13 |
| Embodiment 6 | 14 | 15 | 13 | 15 |
| Embodiment 7 | 16 | 15 | 13 | 10 |
| Embodiment 8 | 15 | 14 | 10 | 8 |
Table 5 shows: embodiment 1-6 stability of viscidity is significantly better than embodiment 7-8, illustrate glutamic acid diacetic acid four sodium and succinyl glycyrrhetinic acid disodium composite, glucose fatty acid phosphate and hydroxypropyl phosphorate starch thickener composite after, viscosity stablization, than being used alone wherein a kind of better effects if.Above-mentioned difference technical characteristic did not have open in the prior art, was not common practise yet.
Claims (4)
1. an aloe facial cleaner, it is characterized in that, be made up of the raw material of following weight portion: Aloe extract 2-4 part, geniposide 4-6 part, puerarin 3-5 part, Inokopolyose 5-7 part, cetyl sulfophenoxy benzenesulfonic acid disodium salt 20-30 part, coconut oil fatty acid monoethanolamide 10-15 part, N-cocamidopropyl propyl amide-DMG inner salt 30-36 part, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt 15-20 part, decanoyl/octanoyl glycerides 5-7 part, distilled water 150-180 part.
2. aloe facial cleaner as claimed in claim 1, it is characterized in that, be made up of the raw material of following weight portion: Aloe extract 2-4 part, geniposide 4-6 part, puerarin 3-5 part, Inokopolyose 5-7 part, cetyl sulfophenoxy benzenesulfonic acid disodium salt 20-30 part, coconut oil fatty acid monoethanolamide 10-15 part, N-cocamidopropyl propyl amide-N, N-dimethylglycine inner salt 30-36 part, hydrogenated cotton seeds oil glyceride disodium sulfosuccinate salt 15-20 part, decanoyl/octanoyl glycerides 5-7 part, glutamic acid diacetic acid four sodium 2-4 part, succinyl glycyrrhetinic acid disodium 3-5 part, glucose fatty acid phosphate 2-4 part, hydroxypropyl phosphorate starch 1-3 part, distilled water 150-180 part.
3. the preparation method of an aloe facial cleaner as claimed in claim 1, it is characterized in that the preparation method of Aloe extract comprises the following steps: get fresh Aloe vera L.var. chinensis(Haw.)Berg. kind, peeling, by Aloe mesophyll homogenate, centrifugal, obtain Aloe juice, hydro-oxidation sodium adjust ph is 7.0-7.4, and spraying dry obtains Aloe extract.
4. the application of aloe facial cleaner in skin-lightening cosmetic as claimed in claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410539505.5A CN104257560B (en) | 2014-10-13 | 2014-10-13 | Aloe facial cleanser and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410539505.5A CN104257560B (en) | 2014-10-13 | 2014-10-13 | Aloe facial cleanser and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104257560A true CN104257560A (en) | 2015-01-07 |
| CN104257560B CN104257560B (en) | 2017-01-11 |
Family
ID=52149224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410539505.5A Active CN104257560B (en) | 2014-10-13 | 2014-10-13 | Aloe facial cleanser and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104257560B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106361646A (en) * | 2016-11-08 | 2017-02-01 | 全椒先奇医药科技有限公司 | Hydrating mask and preparation method thereof |
| CN112912063A (en) * | 2018-10-24 | 2021-06-04 | 株式会社现代百朗德 | Cosmetic composition containing cortex Eucommiae extract for refreshing skin or relieving skin red swelling |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201722210A2 (en) * | 2017-12-27 | 2019-07-22 | Montero Gida Sanayi Ve Ticaret Anonim Sirketi | SENSITIVE COMPOSITIONS FOR CLEANING AND MAINTENANCE |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100114673A (en) * | 2009-04-16 | 2010-10-26 | (주)휴럼 | The manufacturing method of fermented aloe for whitening effect in skin, and the functional whitening cosmetics containing fermented aloe |
| CN102988228A (en) * | 2012-11-26 | 2013-03-27 | 启东市大华电动工具有限公司 | Anti-aging cleansing milk |
| CN103006486A (en) * | 2011-09-21 | 2013-04-03 | 张洪涛 | Heart nourishing and nerve calming bath liquid |
| CN103181874A (en) * | 2011-12-28 | 2013-07-03 | 黄佩英 | Liquid bath wash additive |
| CN103893103A (en) * | 2014-03-22 | 2014-07-02 | 南通蛇类治疗研究所 | Nutrient-element traditional-Chinese-medicament enzyme cleansing milk |
| CN103932944A (en) * | 2014-04-16 | 2014-07-23 | 罗英明 | Pueraria lobata moisturizer and preparation method thereof |
-
2014
- 2014-10-13 CN CN201410539505.5A patent/CN104257560B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100114673A (en) * | 2009-04-16 | 2010-10-26 | (주)휴럼 | The manufacturing method of fermented aloe for whitening effect in skin, and the functional whitening cosmetics containing fermented aloe |
| CN103006486A (en) * | 2011-09-21 | 2013-04-03 | 张洪涛 | Heart nourishing and nerve calming bath liquid |
| CN103181874A (en) * | 2011-12-28 | 2013-07-03 | 黄佩英 | Liquid bath wash additive |
| CN102988228A (en) * | 2012-11-26 | 2013-03-27 | 启东市大华电动工具有限公司 | Anti-aging cleansing milk |
| CN103893103A (en) * | 2014-03-22 | 2014-07-02 | 南通蛇类治疗研究所 | Nutrient-element traditional-Chinese-medicament enzyme cleansing milk |
| CN103932944A (en) * | 2014-04-16 | 2014-07-23 | 罗英明 | Pueraria lobata moisturizer and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106361646A (en) * | 2016-11-08 | 2017-02-01 | 全椒先奇医药科技有限公司 | Hydrating mask and preparation method thereof |
| CN112912063A (en) * | 2018-10-24 | 2021-06-04 | 株式会社现代百朗德 | Cosmetic composition containing cortex Eucommiae extract for refreshing skin or relieving skin red swelling |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104257560B (en) | 2017-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102258442B (en) | Compound traditional Chinese medicine extract and application thereof to whitening, moisturizing and anti-aging skin care product | |
| CN105997836A (en) | Ferment liquid shampoo and preparation method thereof | |
| KR101743197B1 (en) | The manufacturing method of shampoo composition for caring scalp and promoting hair growth, and shampoo composition thereof | |
| CN107937176A (en) | A kind of high-efficiency antioxidant anti-acne handmade soap | |
| CN109662928A (en) | A kind of skin care compositions and its application and preparation method with sun-proof reparation effect | |
| CN103405380B (en) | White fungus skin-care composition and application thereof | |
| CN106214592A (en) | Hair follicle nutrient liquor composition and preparation method thereof | |
| CN104257560B (en) | Aloe facial cleanser and preparation method thereof | |
| CN113122602A (en) | Preparation method and application of quaternized hydrolyzed wheat protein in special anti-hair loss shampoo for women | |
| CN110731976A (en) | Hair loss preventing and hair growing composition | |
| CN100463666C (en) | Composition for preparation for external use on skin and method of using the same | |
| CN106798656B (en) | Deep hair nourishing essence containing yak bone small molecule peptide and preparation method thereof | |
| CN108403522A (en) | A kind of four seasons series toner based on Plant flawer extracts | |
| KR101272375B1 (en) | Soap composition containing black ginseng extract | |
| CN108653137B (en) | Composition and application thereof in preparation of beauty cosmetics | |
| CN108434051A (en) | Hair follicle transdermal absorption traditional Chinese medicinal blood, preparation method and the application in shampoo | |
| CN104398426A (en) | Mask for treating common acne | |
| CN109984953B (en) | Protein peptide gel for bath and skin cleaning and preparation method thereof | |
| CN110974775A (en) | Allergy-relieving composition containing nostoc sphaeroides and preparation method and application thereof | |
| JP2003176218A (en) | Skin care preparation | |
| CN104013549B (en) | Skin care product containing lethariella sinensis extract | |
| CN109260107A (en) | A kind of formula of bath cream and preparation method with the antipruritic function of anti-mite | |
| CN105326779A (en) | Moisturizing, brightening and whitening hair gel and preparation method thereof | |
| CN107805559A (en) | A kind of preparation method of high-efficiency antioxidant anti-acne handmade soap | |
| CN112402268A (en) | Patch type facial mask for preventing and treating acne, preparation method and preparation device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Weifeng Inventor before: Li Zhengmei |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160922 Address after: Anxi County, Quanzhou City, Fujian province 362400 Kui Dou Zhen Qi Guan Cun Ren Temple No. 48 really Applicant after: Chen Weifeng Address before: 211200 Rongchang City, Nanjing province Lishui Yong Yang Town, garden building, room 105, room 27, No. Applicant before: Li Zhengmei |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190724 Address after: 423000 First Floor of 8 Block B Innovation Park, Linyi Avenue, Bailutang Town, Suxian District, Chenzhou City, Hunan Province Patentee after: Hunan biotech Co.,Ltd. Address before: No. 48 Zhenrendian, Miracle Village, Quidou Town, Anxi County Patentee before: Chen Weifeng |
|
| TR01 | Transfer of patent right | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 423000 first floor, block B, building 8, innovation and entrepreneurship Park, Linyi Avenue, bailutang Town, Suxian District, Chenzhou City, Hunan Province Patentee after: Hunan Minyi Technology Co.,Ltd. Address before: 423000 first floor, block B, building 8, innovation and entrepreneurship Park, Linyi Avenue, bailutang Town, Suxian District, Chenzhou City, Hunan Province Patentee before: Hunan biotech Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder |